{"data":{"ticker":"ELVN","name":"Enliven Therapeutics, Inc.","cik":"0001672619","quarterly":[{"frame":"CY2023Q3","end":"2023-09-30","revenue":null,"netIncome":-20769000,"epsDiluted":-0.51,"fiscalPeriod":"Q3 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2023Q4","end":"2023-12-31","revenue":null,"netIncome":-19370000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2024Q1","end":"2024-03-31","revenue":null,"netIncome":-22738000,"epsDiluted":-0.54,"fiscalPeriod":"Q1 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q2","end":"2024-06-30","revenue":null,"netIncome":-19950000,"epsDiluted":-0.41,"fiscalPeriod":"Q2 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q3","end":"2024-09-30","revenue":null,"netIncome":-23156000,"epsDiluted":-0.48,"fiscalPeriod":"Q3 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q4","end":"2024-12-31","revenue":null,"netIncome":-23180000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2025Q1","end":"2025-03-31","revenue":null,"netIncome":-28544000,"epsDiluted":-0.57,"fiscalPeriod":"Q1 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q2","end":"2025-06-30","revenue":null,"netIncome":-25335000,"epsDiluted":-0.49,"fiscalPeriod":"Q2 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q3","end":"2025-09-30","revenue":null,"netIncome":-20148000,"epsDiluted":-0.32,"fiscalPeriod":"Q3 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q4","end":"2025-12-31","revenue":null,"netIncome":-29667000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2026Q1","end":"2026-03-31","revenue":null,"netIncome":-23627000,"epsDiluted":-0.38,"fiscalPeriod":"Q1 FY 2026","fiscalYear":"FY 2026"},{"frame":"CY2026Q2","end":"2026-06-30","revenue":null,"netIncome":-32485000,"epsDiluted":-0.49,"fiscalPeriod":"Q2 FY 2026","fiscalYear":"FY 2026"}],"annual":[{"frame":"CY2020","end":"2020-12-31","fiscalYear":"FY 2020","revenue":null,"netIncome":-41360000,"operatingCashFlow":-37398000,"capex":18000,"buybacks":null,"dividends":null},{"frame":"CY2021","end":"2021-12-31","fiscalYear":"FY 2021","revenue":null,"netIncome":-51384000,"operatingCashFlow":-46771000,"capex":12000,"buybacks":null,"dividends":null},{"frame":"CY2022","end":"2022-12-31","fiscalYear":"FY 2022","revenue":null,"netIncome":-37662000,"operatingCashFlow":-32077000,"capex":612000,"buybacks":null,"dividends":null},{"frame":"CY2023","end":"2023-12-31","fiscalYear":"FY 2023","revenue":null,"netIncome":-71584000,"operatingCashFlow":-61269000,"capex":149000,"buybacks":null,"dividends":null},{"frame":"CY2024","end":"2024-12-31","fiscalYear":"FY 2024","revenue":null,"netIncome":-89024000,"operatingCashFlow":-73192000,"capex":44000,"buybacks":null,"dividends":null},{"frame":"CY2025","end":"2025-12-31","fiscalYear":"FY 2025","revenue":null,"netIncome":-103694000,"operatingCashFlow":-70301000,"capex":158000,"buybacks":null,"dividends":null}],"latest":{"end":"2026-06-30","cash":135505000,"debt":null,"equity":895149000,"assets":910223000,"sharesOutstanding":73270761,"sharesDate":"2026-07-28","form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD","canonicalUrl":"https://xoomar.com/markets/stocks/elvn"},"updatedAt":"2026-11-03T18:41:27.186Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/elvn","meta":{"source":"SEC","sourceAttribution":"Financial statement data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}